CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis

Immunogenetics

Volumn 51, Issue 4-5, 2000, Pages 281-288

  Barcellos, Lisa F ^a   Schito, Anna M ^a   Rimmler, Jackie B ^b   Vittinghoff, Eric ^d   Shih, Andrew ^a   Lincoln, Robin ^a   Callier, Stacy ^a   Elkins, Mary K ^a   Goodkin, Donald E ^a   Haines, Jonathan L ^c   Pericak Vance, Margaret A ^b   Hauser, Stephen L ^a   Oksenberg, Jorge R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Program in Human Genetics   (United States)

^d NONE

Author keywords

Autoimmunity; Chemokine; Human; Major histocompatibility complex; Multiple sclerosis

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; CHROMOSOME 3P; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE DELETION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; SIBLING;

EID: 0034070679     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050621     Document Type: Article

References (45)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5 : a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophages-tropic HIV-1. Science 272:1955-1958
2. Ankel H, Westra D, Welling-Wester S, Lebon P (1998) Induction of interferon alpha by glycoprotein D of herpes simplex virus: a possible role for cytokines. Virology 251:317-326
3. Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Steward GJ (1997) The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol 58:52-59
4. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodoroski J, Springer TA (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV entry. Nature 382:829-833
5. Carrington M, Dean M, Martin MP, O'Brien SJ (1999) Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. Hum Mol Genet 8:1939-1945
6. Chataway JR, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A (1998) The genetics of multiple sclerosis: principles, background and update results of the UK systematic genome screen. Brain 121:1869-1887
7. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148
8. Davis S, Schroeder M, Goldin LR, Weeks DE (1996) Nonparametric simulation-based statistics for detecting linkage in general pedigrees. Am J Hum Genet 58:867-880
9. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural allele. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-1862
10. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666
11. Doolittle TH, Myers RH, Lehrich JR, Birnbaum G, Sheremata W, Franklin GM, Nelson LM, Hauser SL (1990) Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology 40:1546-1552
12. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673
13. Ebers GC, Sadovnick AD (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54:1-17
14. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O'Connor P, Nath A, Auty A, Metz L, Francisc G, Paulseth JE, Murray JT, Pryse-Phillips W, Nelson R, Freedman M, Brunet D, Bouchard J-P, Hinds D, Risch N (1996) A full genome search in multiple sclerosis. Nat Genet 13:472-476
15. Garred P, Madsen H, Petersen J, Marquart H, Hansen T, Sorensen S, Volck B, Svejgaard A, Andersen V (1998) CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 25:1462-1465
16. Godiska R, Chantry D, Dietsch GN, Gray PW (1995) Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58:167-176
17. Goodkin DE, Doolittle TH, Hauser SL, Ransohoff RM, Roses AD, Rudick RA (1991) Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch Neurol 48:805-807
18. Haynes C, Speer MC, Peedin M, Roses AD, Haines JL, Vance JM, Pericak-Vance MA (1995) PEDIGENE: a comprehensive data management system to facilitate efficient and rapid disease gene mapping. Am J Hum Genet 57 [Suppl]:A193
19. Hinds D (1998) The ASPEX package: affected sib-pair exclusion mapping. ftp://lahmed.stanford.edu/pub/aspex
20. Hvas J, McLean C, Justesen J, Kannourakis G, Steinman L, Oksenberg JR, Bernard CCA (1997) Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand J Immunol 46:195-203
21. Jennrich RI, Schlucter MD (1986) Unbalanced repeated-measures models with structured covariance matrices. Biometrics 42:805-820
22. Jiang Y, Salafranca MN, Adhikari S, Xia Y, Feng L, Sonntag MK, deFiebre CM, Pennel NA, Streit WJ, Harrison JK (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 86:1-12
23. Johnson RT (1994) The virology of demyelinating diseases. Ann Neurol 36:S54-S60
24. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller D (1995) An important role for the chemokine macrophage inflammatory protein-1a in the pathogenesis of the cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155:5003-5010
25. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD (1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4:350-353
26. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38:963-974
27. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Nakamura T, Nagai Y, Iwamoto A, Shioda T (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96:4581-4585
28. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-infection. Cell 86:367-377
29. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911
30. Martinson JJ, Chapman NH, Rees DC, Liu Y-T, Clegg JB (1997) Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 16:100-103
31. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM (1998) CCR5 promoter polymorphism and HIV disease progression. Multicenter AIDS cohort study. Lancet 352:866-870
32. Miyagishi R, Kikuchi S, Takayama C, Inoue Y, Tashiro K (1996) Identification of cell types producing RANTES, MIP-1alpha and MIP-1beta in rat experimental autoimmune encepahlomyelitis by in situ hybridization. J Neuroimmunol 77:17-26
33. Multiple Sclerosis Genetics Group (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genetics 13:469-471
34. Multiple Sclerosis Genetics Group (1998a) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 7:1229-1234
35. Multiple Sclerosis Genetics Group (1998b) Clinical demographics of multiplex families with multiple sclerosis. Ann Neurol 43:530-533
36. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835
37. Oksenberg JR, Seboun E, Hauser SL (1996) Genetics of demyelinating diseases. Brain Pathol 6:289-302
38. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464-468
39. Schaffer AA, Gupta SK, Shriram K, Cottingham RW (1994) Avoiding recomputation in linkage analysis. Hum Hered 44:225-237
40. Sorensen TL, Tani M, Jensne J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815
41. Spielman RS, Ewens WJ (1998) A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet 62:450-458
42. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schrimi L, Gerrard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, Giovine FS di, Nasioulas G, Chandler D, Aseev M, Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kanavakis E, Claustres M, Kambouris M, Ostrer H, Dugg G, Baranov V, Sibul H, Goldman D, Martin N, Duffy D, Schmidtke J, Estivill X, O'Brien SJ, Dean M (1998) Dating the origin of the CCR5-Delta 32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 62:1507-1515
43. Terwilliger JD, Weiss KM (1998) Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr Opin Biotechnol 9:578-594
44. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort. Science 279:389-393
45. Xiong M, Jin L (1999) Comparison of the power and accuracy of biallelic and microsatellite markers in population-based gene-mapping methods. Am J Hum Genet 64:629-640